Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 New Facility Presents Manufacturing Solutions For Recombinant Proteins | Contract Pharma
Literature / Brochures

New Facility Presents Manufacturing Solutions For Recombinant Proteins

Grifols' $80 million consolidated manufacturing facility (CMF) is located in Emeryville, California.

With new, state-of-the-art facilities, extensive tech transfer experience and ongoing investments, Grifols provides contract development and manufacturing services for the production of bulk recombinant proteins for use in diagnostics, therapeutics and vaccines.

Our new, $80 million Consolidated Manufacturing Facility (CMF) is located in Emeryville, California. Surrounded and supported by complementary functions and facilities on the Grifols campus, CMF was designed, built and validated to extend our three decades of reliable current Good Manufacturing Practice (cGMP) production of recombinant proteins into the future. The flexible, multiproduct design of CMF and the available manufacturing capacity created an opportunity to leverage our technical expertise and Grifols’ commitment to quality to provide contract services to biopharma companies as a recombinant protein Contract Development and Manufacturing Organization (CDMO).

READ MORE BY FILLING OUT THE FORM >>>>>

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters